Home Cart Sign in  
Chemical Structure| 1811510-56-1 Chemical Structure| 1811510-56-1

Structure of PF-06260933
CAS No.: 1811510-56-1

Chemical Structure| 1811510-56-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PF-06260933 is a selective inhibitor of MAP4K4 with IC50s of 3.7 nM.

Synonyms: PF-6260933

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PF-06260933

CAS No. :1811510-56-1
Formula : C16H13ClN4
M.W : 296.75
SMILES Code : NC1N=CC(C2C=NC(N)=C(C3C=CC(Cl)=CC=3)C=2)=CC=1
Synonyms :
PF-6260933
MDL No. :MFCD30532622

Safety of PF-06260933

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of PF-06260933

MAPK
Hippo

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57B6J mice Subarachnoid hemorrhage model Oral 1, 10, or 100 mg/kg Administered at 15 minutes after SAH PF-06260933 reduced blood-brain barrier damage in mice, promoted the recovery of neurological function, and reduced p-p65 and MMP9 protein expression. PMC7896238
Mouse Ob/ob rodent model Oral 10 mg/kg Twice daily for 4 weeks Evaluate the effect of PF-06260933 on glycemic control, showing significant improvement in fasting hyperglycemia PMC4645242

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.37mL

0.67mL

0.34mL

16.85mL

3.37mL

1.68mL

33.70mL

6.74mL

3.37mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories